Arkolith/Insider Trading/BTAI ]/Form 4

Rodriguez Javier

See RemarksBioXcel Therapeutics, Inc. (BTAI ]) · full profile →Form 4 · filed Dec 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$155
Net Open-Market Flow
-$155
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2024Sell(S)220$0.36$7924K
Dec 16, 2024Sell(S)210$0.36$7625K
Dec 15, 2024Option exercise(M)562——25K
Dec 14, 2024Option exercise(M)521——24K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2024Option exercise(M)562—$05K
Dec 14, 2024Option exercise(M)521—$03K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-129458) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for BioXcel Therapeutics, Inc.

Build

Ask your agent about BTAI ] insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-24-129458"
Ask your agent
Use Arkolith to summarize insider buying and selling at BioXcel Therapeutics, Inc.
over the last 90 days and cite the filings.